Company Filing History:
4 out of 2,169 
1 out of 321 
Years Active: 1998-2003
Title: Innovations and Contributions of Inventor Sung-Uk Kim
Introduction
Sung-Uk Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that have potential therapeutic applications. With a total of five patents to his name, Kim's work is recognized for its innovative approach to addressing complex biological challenges.
Latest Patents
Among his latest patents, one notable invention is a compound that inhibits GRB2-SHC binding. This novel compound, characterized by its high inhibitory activity against Grb2-Shc binding, may be useful for the prevention and treatment of intracellular signal transmission-related diseases. Another significant patent involves the use of naringin and naringenin as inhibitors of acyl CoA-cholesterol-o-acyltransferase. This method aims to inhibit the accumulation of macrophage-lipid complexes on arterial endothelium, thereby preventing or treating hepatic diseases in mammals.
Career Highlights
Sung-Uk Kim has worked with esteemed institutions such as the Korea Institute of Science and Technology and the Korea Research Institute of Bioscience and Biotechnology. His research has contributed to advancements in understanding and treating various health conditions through innovative biochemical approaches.
Collaborations
Throughout his career, Kim has collaborated with notable colleagues, including Kwang-Hee Son and Byoung-Mog Kwon. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of biotechnology.
Conclusion
Sung-Uk Kim's innovative work and patents reflect his dedication to advancing medical science through biotechnology. His contributions are paving the way for new therapeutic strategies that could significantly impact healthcare.